Page 732 - Basic _ Clinical Pharmacology ( PDFDrive )

718 SECTION VII Endocrine Drugs

PREP AR A TIONS Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol
2009;5:374.
A V AIL ABLE Chrousos GP, Kino T: Glucocorticoid signaling in the cell: Expanding clinical
implications to complex human behavioral and somatic disorders. In:
Glucocorticoids and mood: Clinical manifestations, risk factors, and molec-
GENERIC NAME AVAILABLE AS ular mechanisms. Proc NY Acad Sci 2009;1179:153.
GLUCOCORTICOIDS FOR ORAL & PARENTERAL USE * Cutolo M, Chrousos GP, Pincus T: Special issue on glucocorticoid therapy in
Betamethasone Celestone rheumatic diseases. Neuroimmunomodulation. 2015;22:3.
Betamethasone sodium phosphate Generic, Celestone Phosphate Elenkov IJ, Chrousos GP: Stress hormones, TH1/TH2 patterns, pro/anti-inflammatory
cytokines and susceptibility to disease. Trends Endocrinol Metab 1999;10:359.
Budesonide Generic, Entocort EC Elenkov IJ et al: Cytokine dysregulation, inflammation, and wellbeing. Neuroim-
Cortisone Generic munomodulation 2005;12:255.
Dexamethasone Generic, Decadron Franchimont D et al: Glucocorticoids and inflammation revisited: The state of the
Dexamethasone sodium phosphate Generic art. Neuroimmunomodulation 2002–2003;10:247.
Hydrocortisone (cortisol) Generic, Cortef Graber AL et al: Natural history of pituitary-adrenal recovery following long-term
suppression with corticosteroids. J Clin Endocrinol Metab 1965;25:11.
Hydrocortisone acetate Generic Hochberg Z, Pacak K, Chrousos GP: Endocrine withdrawal syndromes. Endocr
Hydrocortisone sodium phosphate Hydrocortone Rev 2003;24:523.
Hydrocortisone sodium succinate Generic, Solu-Cortef, others Kalantaridou S, Chrousos GP: Clinical review 148: Monogenic disorders of
Methylprednisolone Generic, Medrol puberty. J Clin Endocrinol Metab 2002;87:2481.
Methylprednisolone acetate Generic, Depo-Medrol Kino T, Charmandari E, Chrousos G (editors): Glucocorticoid action: Basic and
clinical implications. Ann NY Acad Sci 2004;1024.
Methylprednisolone sodium Generic, Solu-Medrol, others
succinate Kino T et al: The GTP-binding (G) protein β interacts with the activated gluco-
corticoid receptor and suppresses its transcriptional activity in the nucleus.
Prednisolone Generic, Prelone, others J Cell Biol 2005;20:885.
Prednisolone acetate Generic, Flo-Pred Koch CA, Chrousos GP (editors): Endocrine hypertension: Underlying mecha-
Prednisolone sodium phosphate Generic, Hydeltrasol nisms and therapy. In: Contemporary Endocrinology, vol XIII. Springer, 2013.
Prednisone Generic, Deltasone, Prednicot Koch CA, Pacak K, Chrousos GP: The molecular pathogenesis of hereditary and
sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol
Triamcinolone acetonide Generic, Kenalog, Azmacort Metab 2002;87:5367.
Triamcinolone hexacetonide Aristospan Mao J, Regelson W, Kalimi M: Molecular mechanism of RU 486 action: A review.
MINERALOCORTICOIDS Mol Cellular Biochem 1992;109:1.
Fludrocortisone acetate Generic, Florinef Acetate, Marik PE et al: Clinical practice guidelines for the diagnosis and management of
Cortineff Acetate corticosteroid insufficiency in critical illness: Recommendations of an inter-
national task force. Crit Care Med 2008;36:1937.
ADRENAL STEROID INHIBITORS Markou A et al: Stress-induced aldosterone hyper-secretion in a substantial
Abiraterone Zytiga subset of patients with essential hypertension. J Clin Endocrinol Metab.
Ketoconazole Generic, Nizoral 2015;100:2857.
Etomidate Amidate Meduri GU et al: Activation and regulation of systemic inflammation in ARDS:
Rationale for prolonged glucocorticoid therapy. Chest 2009;136:1631.
Mifepristone Mifeprex, Korlym Meduri GU et al: Steroid treatment in ARDS: A critical appraisal of the ARDS
Mitotane Lysodren network trial and the recent literature. Intens Care Med 2008;34:61.
Glucocorticoids for respiratory use: See Chapter 20. Glucocorticoids for dermatologic Merke DP et al: Future directions in the study and management of congenital
use: See Chapter 61. Glucocorticoids for gastrointestinal use: See Chapter 62. adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med
2002;136:320.
Nader N, Chrousos GP, Kino T: Interactions of the circadian CLOCK system and
the HPA axis. Trends Endocrinol Metab 2010;21:277.
REFERENCES Papanastasiou L et al: Primary aldosteronism in hypertensive patients: Clinical
Alesci S et al: Glucocorticoid-induced osteoporosis: From basic mechanisms to implications and target therapy. Eur J Clin Invest. 2014;44:697.
clinical aspects. Neuroimmunomodulation 2005;12:1. Pervanidou P, Kanaka-Gantenbein C, Chrousos GP: Assessment of metabolic
Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of gluco- profile in a clinical setting. Curr Opin Clin Nutr Metab Care 2006;9:589.
corticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Preda VA et al: Etomidate in the management of hypercortisolaemia in Cushing’s
Rev 1996;17:245. syndrome: A review. Eur J Endocrinol 2012;167:137.
Charmandari E et al: Peripheral CLOCK regulates target-tissue glucocorticoid Tsigos C, Chrousos GP: Differential diagnosis and management of Cushing’s
receptor transcriptional activity in a circadian fashion in man. PLoS One syndrome. Annu Rev Med 1996;47:443.
2011;6:e25612. Whitaker MJ et al: An oral multiparticulate, modified-release, hydrocortisone
Charmandari E, Kino T: Chrousos syndrome: A seminal report, a phylogenetic replacement therapy that provides physiological cortisol exposure. Clin
enigma and the clinical implications of glucocorticoid signaling changes. Eur Endocrinol (Oxf) 2014;80:554.
J Clin Invest 2010;40:932. Zannas AS, Chrousos GP. Glucocorticoid signaling drives epigenetic and tran-
Charmandari E, Nicolaides NC, Chrousos GP: Adrenal insufficiency. Lancet. scription factors to induce key regulators of human parturition. Sci Signal
2014;383:2152. 2015;8:fs19.
Charmandari E, Tsigos C, Chrousos GP: Neuroendocrinology of stress. Ann Rev
Physiol 2005;67:259.